Apoptosis Cancer Research Results
Apoptosis, Apoptosis: Click to Expand ⟱
| Source: |
| Type: type of cell death |
Situation in which a cell actively pursues a course toward death upon receiving certain stimuli.
Cancer is one of the scenarios where too little apoptosis occurs, resulting in malignant cells that will not die.
|
Colon, Colon Cancer: Click to Expand ⟱
Colon cancer can start anywhere in the colon, (5 feet long) and absorbs water from stool. Rectal cancer starts in the rectum, which is the last 12 centimeters.
|
Scientific Papers found: Click to Expand⟱
Apoptosis↑, MMP↓, Casp3↑, ROS↑, eff↑,
| - |
in-vitro, |
BC, |
SkBr3 |
|
|
|
- |
in-vitro, |
CRC, |
HT-29 |
|
|
|
- |
in-vitro, |
CRC, |
HCT116 |
|
|
|
- |
in-vitro, |
Colon, |
Caco-2 |
|
|
|
MMP2↓, MMP9↓, ROS↑, TumAuto↑, Apoptosis↑, ER Stress↑,
mt-ROS↑, Apoptosis↑, Casp3↑, DNAdam↑, Bcl-xL↓, Dose↝,
TumCP↓, Casp3↑, EGFR↓, HER2/EBBR2↓, ERK↓, Apoptosis↑,
| - |
in-vitro, |
Colon, |
HT29 |
|
|
|
- |
in-vitro, |
Colon, |
SW48 |
|
|
|
- |
in-vitro, |
Colon, |
SW-620 |
|
|
|
- |
in-vitro, |
CRC, |
HCT116 |
|
|
|
AQPs↓, TumCG↓, TumCCA↓, Apoptosis↑, eff↝,
Apoptosis↑, TNF-α↝,
| - |
in-vitro, |
CRC, |
HCT116 |
|
|
|
- |
in-vitro, |
Colon, |
SW480 |
|
|
|
- |
in-vitro, |
Colon, |
HT29 |
|
|
|
tumCV↓, Apoptosis↑, P53↑, BAX↑, MDM2↓, Bcl-2↓, Bcl-xL↓, Casp9↑, Casp3↑, cl‑PARP↑, STAT3↓, survivin↓, cycD1/CCND1↓, CycD3↓, ROS↑, eff↓, eff↑,
| - |
in-vitro, |
Colon, |
Caco-2 |
|
|
|
- |
in-vitro, |
Colon, |
HT29 |
|
|
|
- |
in-vitro, |
CRC, |
LoVo |
|
|
|
Apoptosis↑, TumCMig↓, uPA↓, MMPs↓, COX2↓, TumCA↓, MMP9↓, MMP2↓, chemoPv↑,
ROS↓, Inflam↓, TumCP↓, Apoptosis↑, *Dose↝, *BioAv↓, *BioAv↑, GSH↑, GSTs↑, PGE2↓, COX1↑, IL8↓, COX2↓, iNOS↓, NF-kB↓, chemoP↑,
| - |
in-vitro, |
Colon, |
LoVo |
|
|
|
- |
in-vitro, |
Colon, |
COLO205 |
|
|
|
- |
in-vitro, |
Pca, |
PC3 |
|
|
|
- |
in-vitro, |
Pca, |
22Rv1 |
|
|
|
NF-kB↓, ATF3↑, HO-1↑, Wnt↓, Akt↓, mTOR↓, PTEN↑, Apoptosis↑, TGF-β↓, PPARγ↑,
| - |
in-vitro, |
Colon, |
CT26 |
|
|
|
- |
in-vivo, |
NA, |
NA |
|
|
|
selectivity↑, ChemoSen↑, BG↓, AminoA↓, Warburg↓, OCR↑, ATP↓, ROS↑, Apoptosis↑, GlucoseCon↓, PI3K↓, PTEN↑, GLUT1↓, GLUT2↓, HK2↓, PFK1↓, PKA↓, ATP:AMP↓, Glycolysis↓, lactateProd↓,
TumCP↓, cycD1/CCND1↓, Apoptosis↑, PI3K↓, Akt↓, ROS↑, Casp3↑, Cyt‑c↑, Bcl-2↓, TumCCA↑, Dose∅, ALP↓, LDH↓, PCNA↓, P53↑, Bax:Bcl2↑,
| - |
in-vitro, |
CRC, |
HCT116 |
|
|
|
- |
in-vitro, |
Colon, |
SW480 |
|
|
|
TumCCA↑, Apoptosis↑,
| - |
in-vitro, |
Colon, |
RKO |
|
|
|
- |
in-vitro, |
Colon, |
HCT116 |
|
|
|
- |
in-vitro, |
Colon, |
HT29 |
|
|
|
Apoptosis↑, TumCCA?, HDAC1↓, DNMT1↓, survivin↓, HDAC↓, P21↑, NF-kB↑, γH2AX↑, ac‑H3↑, DNAdam↑,
| - |
in-vitro, |
Colon, |
HT29 |
|
|
|
- |
in-vitro, |
Nor, |
3T3 |
|
|
|
TumCD↓, ER Stress↑, GRP78/BiP↑, PERK↑, eIF2α↑, ATF4↑, IRE1↑, Apoptosis↑, Casp3↑, Casp7↑, Wnt↓, β-catenin/ZEB1↓, *toxicity∅, UPR↑,
| - |
in-vitro, |
Colon, |
SW480 |
|
|
|
- |
in-vitro, |
Colon, |
Caco-2 |
|
|
|
- |
in-vitro, |
Colon, |
HCT116 |
|
|
|
TumCP↓, TumCMig↓, TumCCA↑, Apoptosis↑, ATM↑, Chk2↑, ATR↑, CHK1↑, CK2↓, cycA1/CCNA1↑, CDK4↓, CDK6↓, cycD1/CCND1↓, cycE/CCNE↓, P53↑, P21↑,
| - |
in-vitro, |
Colon, |
Caco-2 |
|
|
|
- |
in-vitro, |
CRC, |
HCT116 |
|
|
|
TumCG↓, Apoptosis↑, TumCMig↓, MMP2↓, N-cadherin↓, IKKα↓, p‑NF-kB↓, Snail↓, VEGF↓,
Apoptosis↑, *Inflam↓, AntiCan↑, lipid-P↑, COX2↝, MKP1↝,
| - |
in-vitro, |
Lung, |
H157 |
|
|
|
- |
in-vitro, |
BC, |
MCF-7 |
|
|
|
- |
in-vitro, |
Colon, |
HCT15 |
|
|
|
- |
in-vitro, |
Melanoma, |
A375 |
|
|
|
TrxR↓, selectivity↑, eff↑, eff↝, ROS↑, MMP↓, Apoptosis↑, eff↑,
| - |
in-vitro, |
Colon, |
Caco-2 |
|
|
|
- |
in-vitro, |
CRC, |
HCT8 |
|
|
|
TumCG↓, Apoptosis↑,
HH↓, Smo↓, TumCP↓, Apoptosis↑,
| - |
in-vitro, |
BC, |
MDA-MB-231 |
|
|
|
- |
in-vitro, |
Colon, |
SW480 |
|
|
|
- |
in-vitro, |
CRC, |
HCT116 |
|
|
|
TumCG↓, Apoptosis↑,
| - |
in-vitro, |
Colon, |
CX-1 |
|
|
|
- |
in-vitro, |
Colon, |
SW480 |
|
|
|
- |
in-vitro, |
Colon, |
HT-29 |
|
|
|
- |
in-vitro, |
Colon, |
HCT116 |
|
|
|
cycD1/CCND1↓, survivin↓, Wnt/(β-catenin)↓, tumCV↓, TumCCA↑, Apoptosis↑,
| - |
in-vitro, |
Colon, |
HT-29 |
|
|
|
- |
in-vitro, |
Colon, |
SW48 |
|
|
|
TumCCA↑, p27↑, cycD1/CCND1↓, TumCP↓, IGF-1R↓, Akt↓, Wnt↓, P53↑, Apoptosis↑, Sp1/3/4↓, cl‑PARP↑, β-catenin/ZEB1↓, MDM2↓,
| - |
in-vitro, |
GBM, |
A172 |
|
|
|
- |
in-vitro, |
Colon, |
Caco-2 |
|
|
|
- |
in-vitro, |
Pca, |
DU145 |
|
|
|
- |
in-vitro, |
BC, |
MCF-7 |
|
|
|
- |
in-vitro, |
Nor, |
L929 |
|
|
|
*BioAv↑, selectivity↑, AntiCan↑, Apoptosis↑, CHOP↑, GADD34↑, BIM↑, PUMA↑, Ca+2↝,
TumCG↓, Apoptosis↑, MMP↓, Bax:Bcl2↑, Casp3↑, Casp7↑, Casp9↑, ROS↑, e-ERK↑, p38↑, P53∅, eff↓, ChemoSen↑,
Showing Research Papers: 1 to 26 of 26
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 26
Pathway results for Effect on Cancer / Diseased Cells:
Redox & Oxidative Stress ⓘ
ATF3↑, 1, GSH↑, 1, GSTs↑, 1, HO-1↑, 1, lipid-P↑, 1, ROS↓, 1, ROS↑, 7, mt-ROS↑, 1, TrxR↓, 1,
Mitochondria & Bioenergetics ⓘ
ATP↓, 1, MMP↓, 3, OCR↑, 1,
Core Metabolism/Glycolysis ⓘ
AminoA↓, 1, ATP:AMP↓, 1, GlucoseCon↓, 1, GLUT2↓, 1, Glycolysis↓, 1, HK2↓, 1, lactateProd↓, 1, LDH↓, 1, PFK1↓, 1, PPARγ↑, 1, Warburg↓, 1,
Cell Death ⓘ
Akt↓, 3, Apoptosis↑, 26, BAX↑, 1, Bax:Bcl2↑, 2, Bcl-2↓, 2, Bcl-xL↓, 2, BIM↑, 1, Casp3↑, 7, Casp7↑, 2, Casp9↑, 2, Chk2↑, 1, CK2↓, 1, Cyt‑c↑, 1, GADD34↑, 1, iNOS↓, 1, MDM2↓, 2, MKP1↝, 1, p27↑, 1, p38↑, 1, PUMA↑, 1, survivin↓, 3, TumCD↓, 1,
Kinase & Signal Transduction ⓘ
HER2/EBBR2↓, 1, Sp1/3/4↓, 1,
Transcription & Epigenetics ⓘ
ac‑H3↑, 1, tumCV↓, 2,
Protein Folding & ER Stress ⓘ
CHOP↑, 1, eIF2α↑, 1, ER Stress↑, 2, GRP78/BiP↑, 1, IRE1↑, 1, PERK↑, 1, UPR↑, 1,
Autophagy & Lysosomes ⓘ
TumAuto↑, 1,
DNA Damage & Repair ⓘ
ATM↑, 1, ATR↑, 1, CHK1↑, 1, DNAdam↑, 2, DNMT1↓, 1, P53↑, 4, P53∅, 1, cl‑PARP↑, 2, PCNA↓, 1, γH2AX↑, 1,
Cell Cycle & Senescence ⓘ
CDK4↓, 1, cycA1/CCNA1↑, 1, cycD1/CCND1↓, 5, CycD3↓, 1, cycE/CCNE↓, 1, P21↑, 2, TumCCA?, 1, TumCCA↓, 1, TumCCA↑, 5,
Proliferation, Differentiation & Cell State ⓘ
ERK↓, 1, e-ERK↑, 1, HDAC↓, 1, HDAC1↓, 1, HH↓, 1, IGF-1R↓, 1, mTOR↓, 1, PI3K↓, 2, PTEN↑, 2, Smo↓, 1, STAT3↓, 1, TumCG↓, 5, Wnt↓, 3, Wnt/(β-catenin)↓, 1,
Migration ⓘ
Ca+2↝, 1, MMP2↓, 3, MMP9↓, 2, MMPs↓, 1, N-cadherin↓, 1, PKA↓, 1, Snail↓, 1, TGF-β↓, 1, TumCA↓, 1, TumCMig↓, 3, TumCP↓, 6, uPA↓, 1, β-catenin/ZEB1↓, 2,
Angiogenesis & Vasculature ⓘ
ATF4↑, 1, EGFR↓, 1, VEGF↓, 1,
Barriers & Transport ⓘ
AQPs↓, 1, GLUT1↓, 1,
Immune & Inflammatory Signaling ⓘ
COX1↑, 1, COX2↓, 2, COX2↝, 1, IKKα↓, 1, IL8↓, 1, Inflam↓, 1, NF-kB↓, 2, NF-kB↑, 1, p‑NF-kB↓, 1, PGE2↓, 1, TNF-α↝, 1,
Hormonal & Nuclear Receptors ⓘ
CDK6↓, 1,
Drug Metabolism & Resistance ⓘ
ChemoSen↑, 2, Dose↝, 1, Dose∅, 1, eff↓, 2, eff↑, 4, eff↝, 2, selectivity↑, 3,
Clinical Biomarkers ⓘ
ALP↓, 1, BG↓, 1, EGFR↓, 1, HER2/EBBR2↓, 1, LDH↓, 1,
Functional Outcomes ⓘ
AntiCan↑, 2, chemoP↑, 1, chemoPv↑, 1,
Total Targets: 135
Pathway results for Effect on Normal Cells:
Immune & Inflammatory Signaling ⓘ
Inflam↓, 1,
Drug Metabolism & Resistance ⓘ
BioAv↓, 1, BioAv↑, 2, Dose↝, 1,
Functional Outcomes ⓘ
toxicity∅, 1,
Total Targets: 5
Scientific Paper Hit Count for: Apoptosis, Apoptosis
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:31 Cells:% prod#:% Target#:14 State#:% Dir#:2
wNotes=0 sortOrder:rid,rpid
Home Page